Schedule 13G ownership disclosure

SILO PHARMA INC COM

Security class unavailable · CUSIP: 82711P201

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
309,685
Percent of class
9.8670%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-23-011482
Form type
SC 13G/A
Filer
Reda Joseph
CIK
CIK 1952100
Filed
Feb 14, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub